Hepatitis C: A novel point-of-care assay

(Institut Pasteur) One of the major challenges identified by the WHO in efforts to eradicate the hepatitis C virus is the diagnosis of chronic cases that are generally asymptomatic. Major progress is required for new diagnostic techniques that can be 'decentralized,' in other words accessed by populations and countries with limited resources. Scientists from the Institut Pasteur and Inserm, in collaboration with the company genedrive, have developed and validated a rapid, reliable, point-of-care HCV assay.

Source: EurekAlert! - Infectious and Emerging Diseases - April 10, 2018 Category: Infectious Diseases Source Type: news